Analysts think CORT stock price could increase by 97%
Aug 07, 2025, 11:26 AM
1.16%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
6 analysts think CORT stock price will increase by 96.74%. The current median analyst target is $138.72 compared to a current stock price of $70.51. The lowest analysts target is $122.21 and the highest analyst target is $152.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.